These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8451039)

  • 1. LH-RH analogue treatment in adenocarcinoma of the pancreas: a phase II study. Gruppo Ligure per lo Studio del Pancreas.
    Allegretti A; Lionetto R; Saccomanno S; Paganuzzi M; Onetto M; Martinoli C; Rollandi G; Marugo M; Fazzuoli L; Pugliese V
    Oncology; 1993; 50(2):77-80. PubMed ID: 8451039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on prevention of flare-up phenomenon following initial LH-RH analogue administration: combination therapy with diethylstilbestrol].
    Takeuchi S; Yoshida K; Tosaka A; Kobayashi N; Higashi Y; Negishi T
    Hinyokika Kiyo; 1995 Mar; 41(3):191-6. PubMed ID: 7741071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advanced cancer of the exocrine pancreas treated by a long-acting luteinising hormone releasing hormone (LH-RH) analogue, triptorelin: phase II study].
    François E; Lagrange JL; Benchimol D; Hebuterne X; Montoya ML; Fratini G; Rampal P; Richelme H; Namer M
    Ann Chir; 1991; 45(10):909-11. PubMed ID: 1838237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisone.
    Philip PA; Carmichael J; Tonkin K; Buamah PK; Britton J; Dowsett M; Harris AL
    Br J Cancer; 1993 Feb; 67(2):379-82. PubMed ID: 8431370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with an LHRH analogue in patients with advanced pancreatic cancer. A preliminary report.
    Andrén-Sandberg A
    Acta Chir Scand; 1990 Aug; 156(8):549-51. PubMed ID: 2146849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.
    Bolla M; Gonzalez D; Warde P; Dubois JB; Mirimanoff RO; Storme G; Bernier J; Kuten A; Sternberg C; Gil T; Collette L; Pierart M
    N Engl J Med; 1997 Jul; 337(5):295-300. PubMed ID: 9233866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to D-Trp-6-LH-RH in advanced adenocarcinoma of pancreas.
    Gonzalez-Barcena D; Rangel-Garcia NE; Perez-Sanchez PL; Gutierrez-Damperio C; Garcia-Carrasco F; Comaru-Schally AM; Schally AV
    Lancet; 1986 Jul; 2(8499):154. PubMed ID: 2873411
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical effects of a 3-month formulation LH-RH agonist (Zoladex LA 10.8 mg depot) in patients with prostate cancer].
    Kotake T; Akaza H; Usami M; Naito S; Kanetake H; Taguchi T; Tsukagoshi S; Koiso K
    Hinyokika Kiyo; 2001 May; 47(5):349-61. PubMed ID: 11433759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of D-Trp-6-LH-RH on the survival time in patients with advanced pancreatic cancer.
    González-Barcena D; Ibarra-Olmos MA; García-Carrasco F; Gutiérrez-Samperio C; Comaru-Schally AM; Schally AV
    Biomed Pharmacother; 1989; 43(4):313-7. PubMed ID: 2529000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pretreatment with chlormadinone acetate in prostate cancer patients treated with a luteinizing hormone-releasing hormone analogue].
    Yamamoto A; Sumiyoshi Y; Miyake N; Yokozeki H; Kanayama H; Kagawa S
    Hinyokika Kiyo; 1998 Aug; 44(8):557-63. PubMed ID: 9783191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of adenocarcinoma of the pancreas with somatostatin and gonadoliberin (luteinizing hormone-releasing hormone). The French Associations for Surgical Research.
    Huguier M; Samama G; Testart J; Mauban S; Fingerhut A; Nassar J; Houry S; Jaeck D; De Mestier P; Favre JP
    Am J Surg; 1992 Oct; 164(4):348-53. PubMed ID: 1357998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe flare-up in a prostate cancer patient treated with luteinizing hormone-releasing hormone analogue depot.
    Shimizu T; Shibata Y; Uchida T; Satoh J
    Hinyokika Kiyo; 1993 Oct; 39(10):953-5. PubMed ID: 8266863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous manifestations of relapsing polychondritis in a patient receiving goserelin for carcinoma of the prostate.
    Labarthe MP; Bayle-Lebey P; Bazex J
    Dermatology; 1997; 195(4):391-4. PubMed ID: 9529565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Skin reaction induced by subcutaneous injection of LH-RH analogue].
    Segawa N; Nishida T; Hamada S; Azuma H; Katsuoka Y; Nozaki K; Tsuji M
    Hinyokika Kiyo; 2007 Oct; 53(10):695-8. PubMed ID: 18018584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final report on low-dose estramustine phosphate (EMP) monotherapy and very low-dose EMP therapy combined with LH-RH agonist for previously untreated advanced prostate cancer.
    Kitamura T; Suzuki M; Nishimatsu H; Kurosaki T; Enomoto Y; Fukuhara H; Kume H; Takeuchi T; Miao L; Jiangang H; Xiaoqiang L
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S34-40. PubMed ID: 20094950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LH-RH analogues in the treatment of young women with early breast cancer: long-term follow-up of a phase II study.
    Recchia F; Necozione S; Bratta M; Rosselli M; Guerriero G; Rea S
    Int J Oncol; 2015 Mar; 46(3):1354-60. PubMed ID: 25572674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of duct carcinoma of the pancreas with the LH-RH analogue buserelin.
    Friess H; Büchler M; Krüger M; Beger HG
    Pancreas; 1992; 7(5):516-21. PubMed ID: 1513800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen level variations, clinical response to LHRH agonists and changes in the quality of life subscales in metastatic prostate cancer--speculations about possible role of the monoamine system.
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević Z
    Neoplasma; 1997; 44(5):308-13. PubMed ID: 9473791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new LH-RH agonist for treatment of prostate cancer, 3-month controlled-release formulation of goserelin acetate (Zoladex LA 10.8 mg depot)--outline of pre-clinical and clinical studies].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1675-87. PubMed ID: 12355959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal treatment of unresectable pancreatic cancer with LHRH analogue (goserelin).
    Sperti C; Pasquali C; Catalini S; Cappellazzo F; Bonadimani B; Militello C; Pedrazzoli S
    Eur J Surg Oncol; 1992 Jun; 18(3):267-71. PubMed ID: 1535051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.